Optimizing follicular dendritic cell isolation by discontinuous gradient centrifugation and use of the magnetic cell sorter (MACS)

https://doi.org/10.1016/0022-1759(93)90157-3Get rights and content

Abstract

Follicular dendritic cells (FDC) contribute minimally to the total cell population of lymphatic tissue. In order to obtain higher numbers of viable FDC with only a small fraction of contaminating cells the following procedure was developed. Subsequent to the usual mechanical and enzymatical digestion of human tonsils, single cells were layered on top of a discontinuous bovine albumin gradient and centrifuged at 8500 × g. The suspension collected from the 1.052-1.030 interphase contained an average of 10.5% FDC. Next, the preparation was subjected to a new step involving separation of FDC previously treated with biotin-labelled KiM4 monoclonal antibody, raised against FDC, and attached via biotin-streptavidin bonding to streptavidin-conjugated paramagnetic beads. Purification on a magnetic cell sorter (MACS) yielded 3.3−10.1×106 cells with an average FDC content of 78.4%. The viability and morphology of the resulting FDC population was examined using trypan blue staining or electron microscopy. This technique will permit in vitro studies and long term cultures with FDC isolated from human lymphatic tissue.

References (26)

  • G. Janossy et al.

    Double immunofluorescence analysis of lymphoid tissue during HIV-1 infection

  • G.G.B. Klaus et al.

    The follicular dendritic cell: Its role in antigen presentation in the generation of immunological memory

    Immunol. Rev.

    (1980)
  • G. Koopman et al.

    Adhesion of human B cells to follicular dendritic cells involves both the lymphocyte function-associated antigen 1/intercellular adhesion molecule 1 and very late antigen 4/vascular cell adhesion molecule 1 pathways

    J. Exp. Med.

    (1991)
  • Cited by (26)

    • miRNA expression profiling divides follicular dendritic cell sarcomas into two groups, related to fibroblasts and myopericytomas or Castleman's disease

      2016, European Journal of Cancer
      Citation Excerpt :

      Other studies, however, could not corroborate this finding [31]. In previous studies [32] and own attempts, isolation of primary FDCs from tonsils proved to be very sophisticated and not yielding isolates with an appropriate purity. Although no differences were found between the two FDC sarcoma groups on morphologic grounds, PDPN, which was previously described to be expressed in FDCs and FDC sarcomas [20,21], was significantly more frequently expressed in FDC sarcoma group I. PDPN is expressed in cancer-associated fibroblasts [33] and marginal reticular cells [34] and may even be a therapeutic target for FDC sarcoma group I patients in future [35].

    View all citing articles on Scopus

    Part of this work was supported by the Bundesministerium für Forschung und Technologie (Germany) by grant FKZ BGA III-006-89/FVP 6 (P.R. and K.T.-R.).

    View full text